Find Capromorelin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 193273-69-7, Capromorelin tartrate [usan], 193273-69-7 (tartrate), 4150vmf5ep, Cp-424,391-18, Capromorelin tartrate (usan)
Molecular Formula
C32H41N5O10
Molecular Weight
655.7  g/mol
InChI Key
MJGRJCMGMFLOET-MYPSAZMDSA-N
FDA UNII
4150VMF5EP

Capromorelin
1 2D Structure

Capromorelin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[(2R)-1-[(3aR)-3a-benzyl-2-methyl-3-oxo-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]-1-oxo-3-phenylmethoxypropan-2-yl]-2-amino-2-methylpropanamide;(2R,3R)-2,3-dihydroxybutanedioic acid
2.1.2 InChI
InChI=1S/C28H35N5O4.C4H6O6/c1-27(2,29)25(35)30-22(18-37-17-21-12-8-5-9-13-21)24(34)33-15-14-23-28(19-33,26(36)32(3)31-23)16-20-10-6-4-7-11-20;5-1(3(7)8)2(6)4(9)10/h4-13,22H,14-19,29H2,1-3H3,(H,30,35);1-2,5-6H,(H,7,8)(H,9,10)/t22-,28-;1-,2-/m11/s1
2.1.3 InChI Key
MJGRJCMGMFLOET-MYPSAZMDSA-N
2.1.4 Canonical SMILES
CC(C)(C(=O)NC(COCC1=CC=CC=C1)C(=O)N2CCC3=NN(C(=O)C3(C2)CC4=CC=CC=C4)C)N.C(C(C(=O)O)O)(C(=O)O)O
2.1.5 Isomeric SMILES
CC(C)(C(=O)N[C@H](COCC1=CC=CC=C1)C(=O)N2CCC3=NN(C(=O)[C@@]3(C2)CC4=CC=CC=C4)C)N.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
2.2 Other Identifiers
2.2.1 UNII
4150VMF5EP
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 193273-69-7

2. Capromorelin Tartrate [usan]

3. 193273-69-7 (tartrate)

4. 4150vmf5ep

5. Cp-424,391-18

6. Capromorelin Tartrate (usan)

7. 2-amino-n-((1r)-1-(((3ar)-3a-benzyl-2,3,3a,4,6,7-hexahydro-2-methyl-3-oxo-5h-pyrazolo(4,3-c)pyridin-5-yl)carbonyl)-2-(benzyloxy)ethyl)-2-methylpropionamide L-(+)-tartrate (1:1)

8. 2-amino-n-((r)-1-((r)-3a-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-5h-pyrazolo[4,3-c]pyridin-5-yl)-3-(benzyloxy)-1-oxopropan-2-yl)-2-methylpropanamide (2r,3r)-2,3-dihydroxysuccinate

9. Capimorelin Tartrate

10. Cp 424391-18

11. Unii-4150vmf5ep

12. Schembl3837824

13. Capromorelin Tartrate [mi]

14. N-[(2r)-1-[(3ar)-3a-benzyl-2-methyl-3-oxo-6,7-dihydro-4h-pyrazolo[4,3-c]pyridin-5-yl]-1-oxo-3-phenylmethoxypropan-2-yl]-2-amino-2-methylpropanamide;(2r,3r)-2,3-dihydroxybutanedioic Acid

15. Cs-6929

16. Capromorelin Tartrate, >=98% (hplc)

17. Ac-35382

18. Hy-15243

19. S0169

20. D03373

21. A934979

22. Q27258395

23. Cp 424391-18cp 424391-18

24. 2-amino-n-((r)-1-((r)-3a-benzyl-2-methyl-3-oxo-3a,4,6,7-tetrahydro-2h-pyrazolo[4,3-c]pyridin-5(3h)-yl)-3-(benzyloxy)-1-oxopropan-2-yl)-2-methylpropanamide (2r,3r)-2,3-dihydroxysuccinate

25. Propanamide, 2-amino-n-(2-(2,3,3a,4,6,7-hexahydro-2-methyl-3-oxo-3a-(phenyl-methyl)-5h-pyrazolo(4,3-c)pyridin-5-yl)oxo-1-((phenylmethoxy)methyl)ethyl)-2-methyl-,(r-(r*,r*))-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1)

26. Propanamide, 2-amino-n-(2-(2,3,3a,4,6,7-hexahydro-2-methyl-3-oxo-3a-(phenylmethyl)-5h-pyrazolo(4,3-c)pyridin-5-yl)-2-oxo-1-((phenylmethoxy)methyl)ethyl)-2-methyl-, (r-(r*,r*))-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1)

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 655.7 g/mol
Molecular Formula C32H41N5O10
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count12
Rotatable Bond Count12
Exact Mass655.28534252 g/mol
Monoisotopic Mass655.28534252 g/mol
Topological Polar Surface Area232 Ų
Heavy Atom Count47
Formal Charge0
Complexity1010
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

NDC API

read-more
read-more

01

CPHI Middle east
Not Confirmed
arrow
arrow
CPHI Middle east
Not Confirmed

CAPROMORELIN TARTRATE

NDC Package Code : 59116-4950

Start Marketing Date : 2016-12-01

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty